17 studies were initially identified, but 10 studies were excluded due to lacking or unusable data
Origlows two-ingredient formula appealed to me
Tirzepatide is a dual agonist (GLP-1 plus GIP), while semaglutide is a GLP-1 single agonist
Biol Psychiatry 82:472487
Department of Oral Biology, Goldschleger School of Dental Medicine, Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel * Correspondence: Rachel Amir ([email protected]) Received date: 2024-03-26 Accepted date: 2024-10-08 Online published: 2024-10-24 Supported by This work was supported by the Israel Science Foundation (ISF Grant no
Alonso Martin, MD, a licensed physician with a background in neuroscience, family medicine, longevity-focused care, and wellness optimization